We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
-2.9%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$13.2B
AUM Growth
-$2.13B
Cap. Flow
+$212M
Cap. Flow %
1.6%
Top 10 Hldgs %
51.27%
Holding
122
New
17
Increased
44
Reduced
28
Closed
23

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$853M
2
BRMK
Broadmark Realty Capital Inc. Common Stock
BRMK
+$778M
3
AABA
Altaba Inc
AABA
+$385M
4
PPLI
People Inc
PPLI
+$348M
5
BABA icon
Alibaba
BABA
+$288M

Top Sells

Rank Stock Value
1
RHT
Red Hat Inc
RHT
+$964M
2
APC
Anadarko Petroleum
APC
+$738M
3
ARRY
Array Biopharma Inc
ARRY
+$394M
4
BKNG icon
Booking.com
BKNG
+$128M
5
EFX icon
Equifax
EFX
+$117M

Sector Composition

Rank Sector Weight
1 Healthcare 39.58%
2 Technology 13.07%
3 Communication Services 10.54%
4 Industrials 6.1%
5 Consumer Discretionary 5.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TVRD
51
Tvardi Therapeutics
TVRD
$23.1M
$39.3M 0.3%
59,722
+33,296
+126% +$27.7M
S
52
DELISTED
Sprint Corporation
S
$38.5M 0.29%
6,234,186
-4,440,814
-42% -$30.6M
PGNX
53
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$37.2M 0.28%
7,350,000
+1,806,614
+33% +$9.01M
KYNB
54
Kyntra Bio
KYNB
$28.3M
$37M 0.28%
40,000
-28,000
-41% -$30.8M
NXPI icon
55
NXP Semiconductors
NXPI
$58.4B
$35.5M 0.27%
325,000
-105,000
-24% -$10.7M
RC
56
Ready Capital
RC
$279M
$35.1M 0.27%
2,205,132
-38,107
-2% -$578K
FATE icon
57
Fate Therapeutics
FATE
$290M
$34.9M 0.26%
2,250,000
-250,000
-10% -$4.79M
UBER icon
58
PUT
Uber
UBER
$143B
$33.6M 0.25%
+1,102,500
New +$41.5M
EXEL icon
59
Exelixis
EXEL
$13.1B
$30.9M 0.23%
1,750,000
-1,250,000
-42% -$25.3M
AMRN
60
Amarin Corp
AMRN
$301M
$30.3M 0.23%
100,030
-112,470
-53% -$39.3M
ZEAL
61
DELISTED
Zealand Pharma A/S American Depositary Shares
ZEAL
$25.6M 0.19%
1,010,000
+10,000
+1% +$226K
DCPH
62
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$25.5M 0.19%
+750,000
New +$22.2M
NVTA
63
DELISTED
Invitae Corporation
NVTA
$25.1M 0.19%
1,300,000
+400,000
+44% +$9.43M
PTCT icon
64
PTC Therapeutics
PTCT
$5.91B
$24.6M 0.19%
726,986
+126,986
+21% +$5.53M
GEN icon
65
Gen Digital
GEN
$16.8B
$24.3M 0.18%
+1,030,000
New +$24M
VCYT icon
66
Veracyte
VCYT
$3.71B
$24M 0.18%
1,000,000
+650,000
+186% +$17.3M
STML
67
DELISTED
Stemline Therapeutics, Inc.
STML
$23.9M 0.18%
2,300,000
+800,000
+53% +$10.5M
MRTX
68
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$23.4M 0.18%
300,000
-695,000
-70% -$65.2M
CRSP icon
69
CRISPR Therapeutics
CRSP
$4.99B
$23M 0.17%
560,367
+60,367
+12% +$2.88M
TECX
70
Tectonic Therapeutic
TECX
$570M
$21.9M 0.17%
129,167
+42,821
+50% +$9.69M
PVTL
71
DELISTED
Pivotal Software, Inc.
PVTL
$21.3M 0.16%
+1,430,000
New +$17.5M
ONCE
72
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$21.3M 0.16%
220,000
-550,000
-71% -$55.1M
ARWR icon
73
Arrowhead Research
ARWR
$12.1B
$18.3M 0.14%
650,000
-1,350,000
-68% -$40M
PTGX icon
74
Protagonist Therapeutics
PTGX
$9.4B
$18M 0.14%
1,500,000
– –
TCDA
75
DELISTED
Tricida, Inc. Common Stock
TCDA
$15.4M 0.12%
+500,000
New +$16.7M
1 2
3
4 5

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q3 2019 Portfolio in Review

As of Q3 2019, Farallon Capital Management held 122 positions worth $13.2B, down 14% from $15.4B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Farallon Capital Management's Q3 2019 filing shows 17 new, 44 increased, 28 reduced and 23 closed positions. Its largest new stake was Broadmark Realty Capital Inc. Common Stock: 75,000,000 shares worth $77.3M. The largest sale was Red Hat Inc, an estimated $964M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 33% a quarter earlier, followed by Technology and Communication Services.

  • Farallon Capital Management's largest Q3 2019 buy was Broadmark Realty Capital Inc. Common Stock: 75,000,000 shares worth $77.3M.
  • Farallon Capital Management added most to Allergan plc in Q3 2019, an estimated $853M increase.
  • Farallon Capital Management's biggest Q3 2019 reduction was Booking.com, cutting an estimated $128M.
  • Farallon Capital Management fully exited Red Hat Inc in Q3 2019, selling an estimated $964M.
  • Farallon Capital Management's ten largest holdings make up 51% of its $13.2B portfolio in Q3 2019.
  • Farallon Capital Management opened 17 new positions and closed 23 in Q3 2019.
  • Farallon Capital Management's portfolio value fell 14% quarter-over-quarter to $13.2B.

Based on Farallon Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.